プレシジョンメディシンのサプライチェーンロジスティクス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、サービス別、製品別、エンドユーザー別、地域別、競合別、2020～2030年

プレシジョンメディシンのサプライチェーンロジスティクスの世界市場規模は2024年に75億1,000万米ドル、2030年には142億5,000万米ドルに達すると予測され、CAGRは11.24％を記録します。

この市場は、腫瘍学、希少疾患、遺伝的疾患に対する個別化治療の普及により急速に拡大しています。精密医療では、高感度の生物製剤、細胞・遺伝子治療薬、カスタマイズされた診断薬の輸送が要求され、それぞれに精密で、温度管理された、時間的に重要な、患者固有の物流ソリューションが必要とされます。2025年現在、世界中で1万7,000件を超える精密医療関連の臨床試験が実施されており、機敏でコンプライアンスに優れた物流インフラに対するニーズが急増しています。ロジスティクスプロバイダーは、安全なリバースロジスティクス、完全なトレーサビリティ、現場から患者への配送といった機能にますます重点を置くようになっています。IoTセンサー、ブロックチェーン、リアルタイム分析などの強化されたテクノロジーが、この分野のイノベーションを促進しています。また、非中央集権的な臨床試験の増加も、特に複雑な治療レジメンにおける患者への直接配送において、ロジスティクスモデルをより柔軟で患者中心のものへと押し上げています。

市場促進要因

細胞治療と遺伝子治療の採用増加

主な市場課題

個別化治療の取り扱いの複雑さ

主要市場動向

患者への直接投与（DTP）モデルの出現

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のプレシジョンメディシンのサプライチェーンロジスティクス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（臨床、商業）
  • サービス別（輸送、倉庫、調達・購買、その他）
  • 製品別（細胞・遺伝子治療（CGT）、モノクローナル抗体、核酸治療、ワクチン、その他）
  • エンドユーザー別（製薬・バイオ医薬品企業、臨床調査機関、その他）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米のプレシジョンメディシンのサプライチェーンロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州のプレシジョンメディシンのサプライチェーンロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域のプレシジョンメディシンのサプライチェーンロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米のプレシジョンメディシンのサプライチェーンロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのプレシジョンメディシンのサプライチェーンロジスティクス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Almac Group Limited
• Catalent, Inc.
• Parexel International Corporation
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• DHL International GmbH
• Federal Express Corporation
• UPS Healthcare
• GXO Logistics, Inc.
• Marken Limited

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Precision Medicine Supply Chain Logistics Market was valued at USD 7.51 Billion in 2024 and is projected to reach USD 14.25 Billion by 2030, registering a CAGR of 11.24%. This market is expanding rapidly due to the growing adoption of personalized treatments for oncology, rare diseases, and genetic conditions. Precision medicine demands the transportation of highly sensitive biologics, cell and gene therapies, and customized diagnostics-each requiring precise, temperature-controlled, time-critical, and patient-specific logistics solutions. With over 17,000 active precision medicine-related clinical trials worldwide as of 2025, the need for agile and compliant logistics infrastructure has surged. Logistics providers are increasingly focused on capabilities such as secure reverse logistics, full traceability, and site-to-patient delivery. Enhanced technologies-including IoT sensors, blockchain, and real-time analytics-are driving innovation in this space. The rise in decentralized trials is also pushing logistics models to be more flexible and patient-centric, especially for direct-to-patient delivery in complex therapy regimens.

Key Market Drivers

Rising Adoption of Cell and Gene Therapies

The increasing use of cell and gene therapies is a key growth driver in the Precision Medicine Supply Chain Logistics Market. These personalized treatments involve a complex, highly regulated sequence-from harvesting patient samples to lab processing and returning the final product-all under strict time and temperature constraints. In 2023 and 2024 alone, the FDA approved a total of 16 cell and gene therapy products, indicating strong regulatory momentum and growing manufacturing needs. These sensitive therapies require ultra-cold or cryogenic transport to maintain integrity, driving demand for advanced cold-chain logistics, real-time GPS monitoring, and compliance-driven documentation. Providers offering complete traceability, contingency protocols, and certified infrastructure are becoming essential partners for biopharma companies.

Key Market Challenges

High Complexity of Handling Personalized Therapies

Managing personalized therapies presents significant operational challenges in the precision medicine logistics ecosystem. Unlike standard pharmaceuticals, these treatments are custom-made for individual patients and must adhere to narrow time windows and stringent environmental controls. For instance, autologous therapies involve transporting a patient's own cells to and from a specialized facility, necessitating seamless coordination, temperature integrity, and accurate labeling throughout the chain of custody. Any error-be it in customs clearance, labeling, or timing-can jeopardize treatment viability. Each shipment must align precisely with clinical and patient schedules, leaving virtually no room for deviation and amplifying the logistical complexity.

Key Market Trends

Emergence of Direct-to-Patient (DTP) Delivery Models

The growing prominence of Direct-to-Patient (DTP) delivery models is reshaping precision medicine logistics. As therapies become increasingly individualized, delivering treatment directly to patients' homes enhances accessibility and supports decentralized clinical trials. This model improves convenience, adherence, and participation, particularly for patients in remote or mobility-limited settings. DTP logistics requires precise coordination, validated cold-chain packaging, and real-time tracking systems to maintain therapy integrity during transit. Cold chain continuity and regulatory compliance are critical, especially for sensitive biologics. Logistics providers are investing in digital infrastructure and white-glove services-such as in-person delivery, patient education, and reverse logistics-to meet these complex demands. With the continued growth of telehealth and at-home diagnostics, DTP delivery is becoming integral to modern, patient-focused precision medicine.

Key Market Players

• Almac Group Limited
• Catalent, Inc.
• Parexel International Corporation
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• DHL International GmbH
• Federal Express Corporation
• UPS Healthcare
• GXO Logistics, Inc.
• Marken Limited

Report Scope:

In this report, the Global Precision Medicine Supply Chain Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Precision Medicine Supply Chain Logistics Market, By Type:

• Clinical
• Commercial

Precision Medicine Supply Chain Logistics Market, By Service:

• Transportation
• Warehousing
• Sourcing & Procurement
• Others

Precision Medicine Supply Chain Logistics Market, By Product:

• Cell & Gene Therapies (CGT)
• Monoclonal Antibodies
• Nucleic Acid Therapies
• Vaccines
• Others

Precision Medicine Supply Chain Logistics Market, By End User:

• Pharmaceutical and Biopharmaceutical Companies
• Clinical Research Organizations
• Others

Precision Medicine Supply Chain Logistics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Supply Chain Logistics Market.

Available Customizations:

Global Precision Medicine Supply Chain Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Precision Medicine Supply Chain Logistics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Clinical, Commercial)
  • 5.2.2. By Service (Transportation, Warehousing, Sourcing & Procurement, Others)
  • 5.2.3. By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others)
  • 5.2.4. By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Precision Medicine Supply Chain Logistics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Service
  • 6.2.3. By Product
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Precision Medicine Supply Chain Logistics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Service
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Precision Medicine Supply Chain Logistics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Service
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Precision Medicine Supply Chain Logistics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Service
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End User

7. Europe Precision Medicine Supply Chain Logistics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Service
  • 7.2.3. By Product
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Service
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Service
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Service
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Service
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Service
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End User

8. Asia-Pacific Precision Medicine Supply Chain Logistics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Service
  • 8.2.3. By Product
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Service
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End User
  • 8.3.2. India Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Service
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Service
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Service
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Service
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End User

9. South America Precision Medicine Supply Chain Logistics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Service
  • 9.2.3. By Product
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Precision Medicine Supply Chain Logistics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Service
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Precision Medicine Supply Chain Logistics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Service
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Precision Medicine Supply Chain Logistics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Service
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End User

10. Middle East and Africa Precision Medicine Supply Chain Logistics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Service
  • 10.2.3. By Product
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Precision Medicine Supply Chain Logistics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Service
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Precision Medicine Supply Chain Logistics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Service
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Precision Medicine Supply Chain Logistics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Service
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Almac Group Limited
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Catalent, Inc.
• 15.3. Parexel International Corporation
• 15.4. IQVIA Holdings Inc.
• 15.5. Thermo Fisher Scientific Inc.
• 15.6. DHL International GmbH
• 15.7. Federal Express Corporation
• 15.8. UPS Healthcare
• 15.9. GXO Logistics, Inc.
• 15.10. Marken Limited

16. Strategic Recommendations

17. About Us & Disclaimer